ELI LILLY & Co·4

Feb 12, 4:16 PM ET

Hakim Anat 4

4 · ELI LILLY & Co · Filed Feb 12, 2025

Insider Transaction Report

Form 4
Period: 2025-02-10
Hakim Anat
EVP, GC & Secretary
Transactions
  • Award

    Common Stock

    2025-02-10$868.88/sh+10,320.956$8,967,67228,837.5 total
  • Award

    Restricted Stock Unit

    2025-02-10+6,7006,700 total
    From: 2026-02-01Exp: 2026-02-01Common Stock (6,700 underlying)
Holdings
  • Common Stock

    (indirect: By Anat Hakim SLAT)
    14,700
Footnotes (2)
  • [F1]The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Documents

1 file
  • 4
    wk-form4_1739395004.xmlPrimary

    FORM 4